PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways
Mu, Nan; Gu, Jintao; Liu, Nannan; Xue, Xiaochang; Shu, Zhen; Zhang, Kuo; Huang, Tonglie; Chu, Chu; Zhang, Wangqian; Gong, Li; Zhao, Huadong; Jia, Bo; Gao, Dakuan; Shang, Lei; Zhang, Wei; Guo, Qingdong
- 期刊名称Theranostics
- 作者Mu, Nan; Gu, Jintao; Liu, Nannan; Xue, Xiaochang; Shu, Zhen; Zhang, Kuo; Huang, Tonglie; Chu, Chu; Zhang, Wangqian; Gong, Li; Zhao, Huadong; Jia, Bo; Gao, Dakuan; Shang, Lei; Zhang, Wei; Guo, Qingdong
- 卷第8卷
- 期第6期
- 印刷ISSN1838-7640
- 文件大小3741.15KB
- 发表时间2018
- DOI10.7150/thno.22699
- 页码1527-1539